|
Volumn 60, Issue 12, 2002, Pages 2339-2344
|
Pharmacogenetics of disease modifying anti-rheumatic drugs
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
ARYLAMINE ACETYLTRANSFERASE;
METHOTREXATE;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
OXIDOREDUCTASE;
SALAZOSULFAPYRIDINE;
ARTICLE;
GENETIC POLYMORPHISM;
GENETICS;
HUMAN;
METABOLISM;
PHARMACOGENETICS;
RHEUMATOID ARTHRITIS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
ARYLAMINE N-ACETYLTRANSFERASE;
HUMANS;
METHOTREXATE;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
SULFASALAZINE;
|
EID: 0036982263
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|